Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic review.
Furumaya A, Nooijen LE, Haring MPD, van Oers HA, van Beneden M, van Rosmalen BV, Takkenberg RB, Kazemier G, Besselink MG, de Meijer VE, Erdmann JI; Dutch Benign Liver Tumor Group. Furumaya A, et al. Among authors: van rosmalen bv. J Patient Rep Outcomes. 2022 Dec 9;6(1):124. doi: 10.1186/s41687-022-00531-1. J Patient Rep Outcomes. 2022. PMID: 36484883 Free PMC article.
Transarterial (Chemo-)Embolization and Lipiodolization for Hepatic Haemangioma.
Furumaya A, van Rosmalen BV, Takkenberg RB, van Delden OM, Dejong CHC, Verheij J, van Gulik TM. Furumaya A, et al. Among authors: van rosmalen bv, van gulik tm, van delden om. Cardiovasc Intervent Radiol. 2019 Jun;42(6):800-811. doi: 10.1007/s00270-019-02169-x. Epub 2019 Feb 19. Cardiovasc Intervent Radiol. 2019. PMID: 30783780 Free PMC article. Review.
Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Klompenhouwer AJ, et al. Among authors: van rosmalen bv, van gulik tm. Am J Gastroenterol. 2019 Aug;114(8):1292-1298. doi: 10.14309/ajg.0000000000000182. Am J Gastroenterol. 2019. PMID: 30920416
Impact of open and minimally invasive resection of symptomatic solid benign liver tumours on symptoms and quality of life: a systematic review.
van Rosmalen BV, de Graeff JJ, van der Poel MJ, de Man IE, Besselink M, Abu Hilal M, Busch OR, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. van Rosmalen BV, et al. Among authors: van der poel mj, van gulik tm. HPB (Oxford). 2019 Sep;21(9):1119-1130. doi: 10.1016/j.hpb.2019.02.022. Epub 2019 Mar 27. HPB (Oxford). 2019. PMID: 30926331 Free article.
Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G, Sprengers D, Mancham S, Erkens R, Boor PPC, van Beek AA, Doukas M, Noordam L, Campos Carrascosa L, de Ruiter V, van Leeuwen RWF, Polak WG, de Jonge J, Groot Koerkamp B, van Rosmalen B, van Gulik TM, Verheij J, IJzermans JNM, Bruno MJ, Kwekkeboom J. Zhou G, et al. J Hepatol. 2019 Oct;71(4):753-762. doi: 10.1016/j.jhep.2019.05.026. Epub 2019 Jun 11. J Hepatol. 2019. PMID: 31195061
Safety and efficacy of transarterial embolization of hepatocellular adenomas.
van Rosmalen BV, Klompenhouwer AJ, de Graeff JJ, Haring MPD, de Meijer VE, Rifai L, Dokmak S, Rawashdeh A, Abu Hilal M, de Jong MC, Dejong CHC, Doukas M, de Man RA, IJzermans JNM, van Delden OM, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. van Rosmalen BV, et al. Among authors: van gulik tm, van delden om. Br J Surg. 2019 Sep;106(10):1362-1371. doi: 10.1002/bjs.11213. Epub 2019 Jul 17. Br J Surg. 2019. PMID: 31313827 Free PMC article.
23 results